Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer

International Journal of Cancer

Volumn 49, Issue 6, 1991, Pages 886-892

  Aaltomaa, S ^a   Lipponen, P ^a   Eskelinen, M ^a   Kosma, V M ^a,b   Marin, S ^a   Alhava, E ^a   Syrjanen K ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL FEATURE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORPHOMETRICS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMAN; LYMPHATIC METASTASIS; MIDDLE AGE; MULTIVARIATE ANALYSIS; NECROSIS; PROBABILITY; PROGNOSIS; RECURRENCE; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0025836966     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910490615     Document Type: Article

References (35)

1. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer
2. Significance of estrogen and progesterone receptors, disease‐free interval, and site of first metastasis on survival of breast cancer patients
3. The value of morphometry to classic prognosticators in breast cancer
4. Histological grading and prognosis in breast cancer
5. Have changing treatment patterns affected outcome for operable breast cancer?
6. Regression models and life tables with discussion
7. An improved prognostic index of axillary node involvement in breast cancer incorporating DNA ploidy and tumour size
8. Relationship between DNA ploidy and survival in patients with exocrine pancreatic cancer
9. Relationship between DNA ploidy and survival in patients with primary breast cancer
10. Ploidy analysis and S‐phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast
11. Prognosis of ovarian carcinomas: prediction by histoquantitative methods
12. Volume corrected mitotic index (M/V index)—the standard of mitotic activity in neoplasms
13. Association of DNA index and S phase fraction with prognosis of node‐positive early breast cancer
14. Prognostic significance of flow cytometric DNA analysis in node‐negative breast cancer
15. Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer
16. Relationship between DNA flow cytometric data, nuclear morphometric variables and volume corrected mitotic index in transitional cell bladder tumors
17. Progression and survival in transitional cell bladder cancer. A comparison of established prognostic factors, S‐phase fraction and DNA ploidy
18. Prediction of superficial bladder cancer by histoquantitative methods
19. Potential of nuclear morphometry and volume corrected mitotic index in rading transitional cell carcinoma of the urinary bladder
20. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components
21. Node negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry
22. Prognosis of breast cancer. Recognition of lethal and favourable prognostic types
23. Ductal carcinoma in situ with microinvasion
24. Tumor‐host interrelationship in carcinoma of the female breast
25. Histological grading of breast cancer. Interobserver reproducibility and prognostic significance
26. The prognostic significance of nuclear DNA content in invasive breast cancer—a study with long‐term follow‐up
27. Nuclear DNA content as a prognostic factor in T1‐2N0 breast cancer
28. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast cancer patients with long follow‐up
29. Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer
30. Breast conservation is the treatment of choice in small breast cancer: long term results of a randomized trial
31. Quadrantectomy versus lumpectomy for small size breast cancer